Reversible Hair Loss in Lichen Planopilaris | Great Cases from the JDD
INTRODUCTION Lichen planopilaris (LPP) is a cicatricial alopecia that presents with patchy or diffuse hair loss at the vertex or parietal scalp. Although there is no gold standard therapy, most interventions are immune modulating and aimed at reducing inflammation and terminating the scarring process to prevent further fibrosis.3 Even amongst patients who respond to therapy, hair …
Continue reading “Reversible Hair Loss in Lichen Planopilaris | Great Cases from the JDD”
JDD February 2023 Issue Highlights
The February issue of the Journal of Drugs in Dermatology (JDD) includes the perfect blend of original articles, case reports, and brief communications exploring topics such as efficacy and safety of 1% clascoterone cream in patients aged ≥12 years with acne vulgaris, dupilumab’s impact on atopic dermatitis among adolescent and adult patients, development and validation …
The “Flolan Rash” | Great Cases from the JDD
INTRODUCTION Epoprostenol (Flolan) is a last-resort intravenous (IV) medication for the treatment of severe pulmonary arterial hypertension (PAH). Cutaneous adverse events of Flolan are well-known by pulmonologists, though lacking in dermatologic literature.1 We report an extensive near erythrodermic appearing asymptomatic eruption following long-term use of epoprostenol. This characteristic and striking eruption associated with Flolan necessitates awareness …
Continue reading “The “Flolan Rash” | Great Cases from the JDD”
Refractory Alopecia Areata and Vitiligo Responding to Tofacitinib Monotherapy
INTRODUCTION Tofacitinib is a Janus kinase (JAK) 1-3 inhibitor first U.S. Food and Drug Administration (FDA) approved in 2012 for rheumatoid arthritis, with subsequent approval for psoriatic arthritis, ulcerative colitis, polyarticular course juvenile idiopathic arthritis, and ankylosing spondylitis in 2017, 2018, 2020, and 2021, respectively.1,2 In the last several years, oral tofacitinib has become an increasingly …
Continue reading “Refractory Alopecia Areata and Vitiligo Responding to Tofacitinib Monotherapy”
Severe Psoriasis Presenting in 3-Year-Old Child With Nail Dystrophy: Response to Biologic Treatment
Psoriasis, a chronic inflammatory skin condition, affects about 2% of children. A small subset have isolated nail involvement refractory to topical treatment that can be disabling. The development of targeted biologic agents offers safe, effective options for children with moderate-to-severe skin and nail disease. A few are now Food and Drug Administration (FDA)-approved for children. …
JDD November 2022 Issue Highlights | Lasers, Light Sources, and Devices
The November issue of the Journal of Drugs in Dermatology (JDD) focuses on lasers, lights sources, and devices featuring original articles and case reports exploring topics such as combination of platelet rich plasma and 1550 nm fractional laser for androgenetic alopecia, safety of combination laser procedures in single clinic visit, efficacy of a fractionated 1540 …
Continue reading “JDD November 2022 Issue Highlights | Lasers, Light Sources, and Devices”
Pediatric Verrucous Psoriasis: A Case Report in a Pediatric Patient
Verrucous psoriasis (VP) is a rare histologic variant of psoriasis. To date, fewer than 40 cases have been reported, with pediatric cases representing an exceedingly small fraction. Treatment options are limited, and the disease is often refractory to conventional methods. Herein, JDD authors Samantha Sherkin OMS-IV, Christian Summa OMS-IV, David Crasto DO, Zackary Whitney DO, …
Continue reading “Pediatric Verrucous Psoriasis: A Case Report in a Pediatric Patient”
JDD September Issue Highlights | Special Focus: Aesthetic Treatments
The September issue of the Journal of Drugs in Dermatology (JDD) focuses on aesthetic treatments and features original articles exploring topics such as reconstruction of the glabella and nasal root, perioral rejuvenation with high molecular weight HA and amino acid treatment, blue light and skin health, and many more. Check out this month’s issue highlights straight …
Continue reading “JDD September Issue Highlights | Special Focus: Aesthetic Treatments”
JDD August Issue Highlights | Special Focus: Psoriasis
The August issue of the Journal of Drugs in Dermatology (JDD) focuses on Psoriasis and features mix of original articles, editorials, and case reports. Among many of the topics explored in this issue are treatment of scalp psoriasis, nail psoriasis, respiratory tract infections in patients using biologics for hidradenitis suppurativa, classification of actinic keratosis, lichen …
Continue reading “JDD August Issue Highlights | Special Focus: Psoriasis”
JDD July Issue Highlights | Skin of Color Issue
The July issue of the Journal of Drugs in Dermatology (JDD) focuses on skin of color topics with the perfect mix of original articles, case reports, brief communications, and letters to the editor. Among many of the topics explored in this issue are skin of color dermatology on TikTok, disparities in melanoma recognition in skin …
Continue reading “JDD July Issue Highlights | Skin of Color Issue”